Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Histone deacetylases (HDACs) mediate changes in nucleosome conformation and are important in the regulation of gene expression. HDACs are involved in cell-cycle progression and differentiation, and their deregulation is associated with several cancers. HDAC inhibitors, such as trichostatin A (TSA) and suberoylanilide hydroxamic acid (SAHA), have anti-tumour effects, as they can inhibit cell growth, induce terminal differentiation and prevent the formation of tumours in mice models, and they are effective in the treatment of promyelocytic leukemia. Here we describe the structure of the histone deacetylase catalytic core, as revealed by the crystal structure of a homologue from the hyperthermophilic bacterium Aquifex aeolicus, that shares 35.2% identity with human HDAC1 over 375 residues, deacetylates histones in vitro and is inhibited by TSA and SAHA. The deacetylase, deacetylase-TSA and deacetylase-SAHA structures reveal an active site consisting of a tubular pocket, a zinc-binding site and two Asp-His charge-relay systems, and establish the mechanism of HDAC inhibition. The residues that make up the active site and contact the inhibitors are conserved across the HDAC family. These structures also suggest a mechanism for the deacetylation reaction and provide a framework for the further development of HDAC inhibitors as antitumour agents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The conformation of this loop is virtually identical in the three HDLP structures (Finnin et al., 1999), suggesting that the surface of HDLP is less malleable than that of HDAC8 around the binding site pocket.”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Finnin et al., 1999
In the citing paper
“The apparent reduced flexibility in the HDLP surface may also explain why it is less efficient in histone deacetylase assays (Finnin et al., 1999).”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Finnin et al., 1999
In the citing paper
“Finnin et al. (1999) have suggested that H143 protonates the lysine after the carbon-nitrogen scissile bond breaks.”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Finnin et al., 1999
In the citing paper
“HDAC6 also contributes to mitochondrial trafficking and misfolded protein clearance (Perry et al., 2017; Finnin et al., 1999), highlighting the HDAC6–microtubule–mitochondria axis as an important regulatory node beyond chromatin-dependent mechanisms.”
From Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook (2026) · cites this paper as Finnin et al., 1999
In the citing paper
“HDAC6 also contributes to mitochondrial trafficking and misfolded protein clearance (Perry et al., 2017; Finnin et al., 1999), highlighting the HDAC6–microtubule–mitochondria axis as an important regulatory node beyond chromatin-dependent mechanisms.”
From Histone modifications and depression: epigenetic mechanisms, therapeutic targets, and translational outlook (2026) · cites this paper as Finnin et al., 1999
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
[26] Raster3D: Photorealistic molecular graphics
Merritt, E. A., & Bacon, D. J. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)77028-9 · Cited by 3,739
The relation between the divergence of sequence and structure in proteins.
Chothia, C., & Lesk, A. M. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04288.x · Cited by 2,458
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Histone acetylation and transcriptional regulatory mechanisms
Struhl, K. (1998) · Genes & Development · doi:10.1101/gad.12.5.599 · Cited by 1,815
The complete genome of the hyperthermophilic bacterium Aquifex aeolicus
Deckert, G., Warren, P. V., Gaasterland, T., Young, W. G., Lenox, A. L., Graham, D. E., Overbeek, R., Snead, M. A., Keller, M., Aujay, M., et al. (1998) · Nature · doi:10.1038/32831 · Cited by 1,097
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
Richon, V. M., Emiliani, S., Verdin, E., Webb, Y., Breslow, R., Rifkind, R. A., & Marks, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3003 · Cited by 914
Self-citation
Research works printed but not linked: 2
- Cohen,L. A. et al. Inhibition of N-methylnitrosourea-induced tumours by the cytodifferentiating agent, suberanilohydroxamic acid (SAHA). Proc. AACR 39, 108, abstr. 736 (1998).
- Desai,D., El-Bayoumy,K. & Amin,S. Chemopreventive efficacy of suberanilohydroxamic acid (SAHA), a cytodifferentiating agent, against tobacco-specific nitrosamine 4-(methylinitros-amino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in female A/J mice. Proc. AACR 40, 2396, abstr. 362 (1999).
Cited by
Items 901–1,000 of 1,007
Kim, H. M., Ryu, D.-K., Choi, Y., Park, B. W., Lee, K., Han, S., Lee, C.-W., Kang, M., Kang, J. S., Boovanahalli, S. K., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0613828 · Cited by 30
Developing new drugs for the treatment of lymphoma
O’Connor, O. A. (2005) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2005.00470.x · Cited by 29
Suzuki, T., Matsuura, A., Kouketsu, A., Hisakawa, S., Nakagawa, H., & Miyata, N. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.04.002 · Cited by 29
Pirali, T., Faccio, V., Mossetti, R., Grolla, A. A., Micco, S. D., Bifulco, G., Genazzani, A. A., & Tron, G. C. (2009) · Molecular Diversity · doi:10.1007/s11030-009-9153-9 · Cited by 29
Ning, C., Bi, Y.-J., He, Y., Huang, W., Liu, L., Li, Y., Zhang, S.-H., Liu, X., & Yu, N. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.09.051 · Cited by 29
Twist2-Driven Chromatin Remodeling Governs the Postnatal Maturation of Dermal Fibroblasts
Kim, J. Y., Park, M., Ohn, J., Seong, R. H., Chung, J. H., Kim, K. H., Jo, S. J., & Kwon, O. (2021) · Cell Reports · doi:10.1016/j.celrep.2022.110821 · Cited by 29
Skarpidi, E., Cao, H., Heltweg, B., White, B. F., Marhenke, R. L., Jung, M., & Stamatoyannopoulos, G. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(02)01030-5 · Cited by 29
The Theoretical Basis of Transcriptional Therapy of Cancer: Can It Be Put Into Practice?
Melnick, A. M., Adelson, K. B., & Licht, J. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.498 · Cited by 29
Jane, E. P., Premkumar, D. R., Addo‐Yobo, S. O., & Pollack, I. F. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155705 · Cited by 29
Goldstein, L. J., Zhao, F., Wang, Μ., Swaby, R. F., Sparano, J. A., Meropol, N. J., Bhalla, K. N., Pellegrino, C. M., Alpaugh, R. K., Falkson, C. I., et al. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4310-9 · Cited by 29
Shivashimpi, G. M., Amagai, S., Kato, T., Nishino, N., Maeda, S., Nishino, T. G., & Yoshida, M. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.08.041 · Cited by 29
Novel chemotherapy using histone deacetylase inhibitors in cervical cancer.
Takai, N., Kira, N., Ishii, T., Nishida, M., Nasu, K., & Narahara, H. (2011) · PubMed · Cited by 29
Wang, N., Peng, Y., Su, X., Prabhakar, N. R., & Nanduri, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.688322 · Cited by 29
Sinha, S., Tyagi, C., Goyal, S., Jamal, S., Somvanshi, P., & Grover, A. (2016) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2015.1113386 · Cited by 29
Design, synthesis and biological evaluation of novel hydroxamic acids bearing artemisinin skeleton
Hà, V. T. T., Kien, V. T., Binh, L. H., Tiến, V. Đ., My, N. T. T., Nam, N., Baltas, M., Hahn, H., Han, B. W., Thảo, Đ. T., et al. (2016) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2016.03.008 · Cited by 29
Wu, Y., Dai, W., Chen, X., Geng, A., Chen, Y., Lu, T., & Zhu, Y. (2017) · RSC Advances · doi:10.1039/c7ra08835c · Cited by 29
Lee, H.-S., Park, M.-H., Yang, S.-J., Jung, H.-Y., Byun, S.-S., Lee, D., Yoo, H., Yeom, Y. I., & Seo, S. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.1497 · Cited by 29
Tago, T., & Toyohara, J. (2018) · Molecules · doi:10.3390/molecules23020300 · Cited by 28
“In silico modeling suggested that the modified structure would bind to the active site of an HDAC-like protein [63].”
BackgroundProdrugs in Oncology: Bioactivation and Impact on Therapeutic Efficacy and Toxicity
Kurian, R., & Wang, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26030988 · Cited by 28
Leng, S. L., Leeding, K. S., Gibson, P. R., & Bach, L. A. (2001) · Carcinogenesis · doi:10.1093/carcin/22.10.1625 · Cited by 28
Histone Deacetylase Inhibitors: Structure-Based Modeling and Isoform-Selectivity Prediction
Silvestri, L., Ballante, F., Mai, A., Marshall, G. R., & Ragno, R. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300160y · Cited by 28
Thangapandian, S., John, S., & Lee, K. W. (2012) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2012.10507409 · Cited by 28
Mai, A., Valente, S., Nebbioso, A., Simeoni, S., Ragno, R., Massa, S., Brosch, G., Bellis, F. D., Manzo, F., & Altucci, L. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.09.002 · Cited by 28
Ieda, N., Yamada, S., Kawaguchi, M., Miyata, N., & Nakagawa, H. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.04.042 · Cited by 28
HDAC as a Therapeutic Target for Treatment of Endometrial Cancers
Ren, J., Zhang, J., Cai, H., Li, Y., Zhang, Y., Zhang, X., Zhao, D., Li, Z., Ma, H., Wang, J., et al. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990528 · Cited by 28
Histone acetylation-independent transcription stimulation by a histone chaperone
Kato, K., Miyaji‐Yamaguchi, M., Okuwaki, M., & Nagata, K. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl1077 · Cited by 28
Aboumanei, M. H., Abdelbary, A. A., Ibrahim, I. T., Tadros, M. I., & El‐Kolaly, M. T. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.05.010 · Cited by 28
Preclinical Studies of Novel Targeted Therapies
Hideshima, T., & Anderson, K. C. (2007) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2007.08.013 · Cited by 28
Hanaya, K., Suetsugu, M., Saijo, S., Yamato, I., & Aoki, S. (2012) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-012-0873-4 · Cited by 28
Zi, C., Xu, F.-Q., Li, G., Li, Y., Ding, Z., Zhou, J., Jiang, Z., & Hu, J. (2013) · Molecules · doi:10.3390/molecules181113992 · Cited by 28
Oroxylin A inhibits the migration of hepatocellular carcinoma cells by inducing NAG-1 expression
Huo, T., Wang, X., Yu, Z., Kong, B., He, Y. Z., Guo, Q., Zhang, X., & Qiang, L. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00695-4 · Cited by 28
Lactam based 7-amino suberoylamide hydroxamic acids as potent HDAC inhibitors
Taddei, M., Cini, E., Giannotti, L., Giannini, G., Battistuzzi, G., Vignola, D., Vesci, L., & Cabri, W. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.11.072 · Cited by 28
Deubzer, H. E., Busche, B., Rönndahl, G., Eikel, D., Michaelis, M., Cinatl, J. J., Schulze, S., Nau, H., & Witt, O. (2006) · Leukemia Research · doi:10.1016/j.leukres.2006.01.009 · Cited by 28
Chemodivergent Photocatalytic Synthesis of Dihydrofurans and β,γ‐Unsaturated Ketones
Quintavalla, A., Veronesi, R., Carboni, D., Martinelli, A., Zaccheroni, N., Mummolo, L., & Lombardo, M. (2021) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.202100260 · Cited by 28
Multi-targeted hybrids based on HDAC inhibitors for anti-cancer drug discovery
Seo, S. (2012) · Archives of Pharmacal Research · doi:10.1007/s12272-012-0221-9 · Cited by 28
Combining Emerging Agents in Advanced Breast Cancer
Luu, T. H., Chung, C. T., & Somlo, G. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0345 · Cited by 28
Karati, D., Mukherjee, S., & Roy, S. (2024) · Medical Oncology · doi:10.1007/s12032-024-02303-x · Cited by 27
Joshi, G., Yadav, U. P., Rafiq, Z., Grewal, P., Kumar, M., Singh, T., Jha, V., Sharma, P., Eriksson, L. A., Srinivas, L., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02135 · Cited by 27
Zhang, Y., Feng, J., Jia, Y., Xu, Y., Liu, C., Fang, H., & Xu, W. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.08.045 · Cited by 27
Troglitazone inhibits histone deacetylase activity in breast cancer cells
Davies, G. F., Ross, A. R. S., Arnason, T., Juurlink, B. H. J., & Harkness, T. A. A. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.07.011 · Cited by 27
Minoshima, M., Matsumoto, T., & Kikuchi, K. (2014) · Analytical Chemistry · doi:10.1021/ac501881s · Cited by 27
Targeting histone deacetylases: Emerging applications beyond cancer
Raouf, Y. S. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104094 · Cited by 27
Chang, Y., Huang, L., Chen, Y., Wang, Y.-W., Hueng, D., & Huang, S. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.003 · Cited by 27
Acetylation and Histone Deacetylase Inhibitors in Cancer
Kortenhorst, M. S. Q., Carducci, M. A., & Shabbeer, S. (2006) · Analytical Cellular Pathology · doi:10.1155/2006/760183 · Cited by 27
Histone deacetylase inhibitors in myelodysplastic syndrome
Bhalla, K. N., & List, A. F. (2004) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.08.011 · Cited by 27
Tsai, W.-B., Long, Y., Chang, J. T., Savaraj, N., Feun, L. G., Jung, M., Chen, H. H. W., & Kuo, M. T. (2017) · Scientific Reports · doi:10.1038/s41598-017-11445-0 · Cited by 27
Ganai, S. A., Shanmugam, K., & Mahadevan, V. (2014) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2013.879073 · Cited by 27
Lee, K., Kim, J. H., Park, J., Kim, H., Song, S., Kim, S. G., Kim, T. Y., Jong, H.-S., Jung, K. H., Im, S., et al. (2006) · PubMed · Cited by 27
Ganai, S. A. (2016) · Journal of Chemotherapy · doi:10.1080/1120009x.2016.1145375 · Cited by 27
Chen, X., Zhao, S., Wu, Y., Chen, Y., Lu, T., & Zhu, Y. (2016) · RSC Advances · doi:10.1039/c6ra21271a · Cited by 27
Lu, H. K., Gray, L. R., Wightman, F., Ellenberg, P. C., Khoury, G., Cheng, W., Mota, T. M., Wesselingh, S. L., Gorry, P. R., Cameron, P. U., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113341 · Cited by 27
Chittari, P., Gregg, B. T., Kitchen, D. B., Chen, Z. J., & Judkins, A. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.11.006 · Cited by 27
Epigenetic Mechanisms Regulate Stem Cell Expressed Genes Pou5f1 and Gfra1 in a Male Germ Cell Line
Godmann, M., May, E. M., & Kimmins, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012727 · Cited by 27
Synthesis and anticancer evaluation of α-lipoic acid derivatives
Zhang, S., Ge, Q., Guo, D., Hu, W., & Liu, H. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.03.112 · Cited by 27
Novel siderophore, JBIR-16, isolated from Nocardia tenerifensis NBRC 101015
Mukai, A., Komaki, H., Takagi, M., & Shin‐ya, K. (2009) · The Journal of Antibiotics · doi:10.1038/ja.2009.84 · Cited by 27
Elaut, G., Laus, G., Alexandre, E., Richert, L., Bachellier, P., Tourwé, D., Rogiers, V., & Vanhaecke, T. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.116202 · Cited by 26
“, 2003) and the HDAC inhibition mechanism (Finnin et al., 1999), the acid metabolites 3 and 6 do not significantly inhibit rat hepatocyte HDAC in the concentration range tested.”
BackgroundBasavarajappa, B. S., & Subbanna, S. (2024) · Epigenomics · doi:10.2217/epi-2023-0428 · Cited by 26
Histone deacetylase inhibitors: clinical implications for hematological malignancies
Tambaro, F. P., Dell’Aversana, C., Carafa, V., Nebbioso, A., Radic-Sarikas, B., Ferrara, F., & Altucci, L. (2010) · Clinical Epigenetics · doi:10.1007/s13148-010-0006-2 · Cited by 26
Rajak, H., Kumar, P., Parmar, P., Thakur, B. S., Veerasamy, R., Sharma, P. C., Sharma, A., Gupta, A. K., & Dangi, J. S. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.03.058 · Cited by 26
Conejo‐García, A., McDonough, M. A., Loenarz, C., McNeill, L. A., Hewitson, K. S., Ge, W., Liénard, B. M. R., Schofield, C. J., & Clifton, I. J. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.08.032 · Cited by 26
Kalyaanamoorthy, S., & Chen, Y. P. (2013) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2013.05.002 · Cited by 26
Sixto‐López, Y., Gómez-Vidal, J. A., & Correa‐Basurto, J. (2014) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-014-0976-1 · Cited by 26
Shi, Y., Gu, J., Park, J.-Y., Xu, Y.-P., Yu, F.-S., Zhou, L., & Mi, Q. S. (2012) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2012.09.001 · Cited by 26
HDAC inhibitors: Promising agents for leukemia treatment
Deng, Y., Qian, C., & He, J. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.09.023 · Cited by 26
Nasrollahzadeh, M. S., Eskandarpour, V., Maleki, M. F., Eisvand, F., Mashreghi, M., Hadizadeh, F., Tayarani‐Najaran, Z., & Ghodsi, R. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.136951 · Cited by 26
Ganai, S. A. (2016) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1135966 · Cited by 26
Frère, A., Baroni, A., Hendrick, E., Delvigne, A.-S., Orange, F., Peulen, O., Dakwar, G. R., Diricq, J., Dúbois, P., Évrard, B., et al. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b15064 · Cited by 26
Antiproliferative effect of trichostatin a and hc-toxin in T47D Human breast cancer cells
Joung, K. E., Kim, D., & Sheen, Y. Y. (2004) · Archives of Pharmacal Research · doi:10.1007/bf02980164 · Cited by 26
Chemical probes in plant epigenetics studies
Zhang, H., Wang, B., Duan, C., & Zhu, J. (2013) · Plant Signaling & Behavior · doi:10.4161/psb.25364 · Cited by 26
Eikel, D., Hoffmann, K., Zoll, K., Lampen, A., & Nau, H. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008078 · Cited by 25
Kovács‐Kása, A., Kovács, L., Cherian‐Shaw, M., Patel, V. S., Meadows, M. L., Fulton, D. J., Su, Y., & Verin, A. D. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30053 · Cited by 25
Hao, C., Huang, J., Yan, L., Chen, Q., Hu, Z., Niu, J., Wei, R., Kang, Y., Li, H., Lu, T., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.114082 · Cited by 25
Highly fluorescent and HDAC6 selective scriptaid analogues
Fleming, C. L., Natoli, A. L., Schreuders, J., Devlin, M. G., Yoganantharajah, P., Gibert, Y., Leslie, K. G., New, E. J., Ashton, T. D., & Pfeffer, F. M. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.11.020 · Cited by 25
Identification of an Intrinsic Determinant Critical for Maspin Subcellular Localization and Function
Dzinic, S. H., Kaplun, A., Li, X., Bernardo, M. M., Meng, Y., Dean, I. S., Krass, D., Stemmer, P. M., Shin, N., Lonardo, F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074502 · Cited by 25
Bridged bicyclic peptides: Structure and function
Thombare, V. J., & Hutton, C. A. (2018) · Peptide Science · doi:10.1002/pep2.24057 · Cited by 25
Wahi, A., Jain, P., Sinhari, A., & Jadhav, H. R. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02674-4 · Cited by 25
Quantum mechanical/molecular mechanical studies of zinc hydrolases
Xu, D., Cui, Q., & Guo, H. (2014) · International Reviews in Physical Chemistry · doi:10.1080/0144235x.2014.889378 · Cited by 25
CD81, a cell cycle regulator, is a novel target for histone deacetylase inhibition in glioma cells
Gensert, J. M., Baranova, O. V., Weinstein, D. E., & Ratan, R. R. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.03.008 · Cited by 25
Recent Advances in Medicinal Chemistry of Histone Deacetylase Inhibitors
Weinmann, H., & Ottow, E. (2004) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(04)39015-9 · Cited by 25
Histone Deacetylase Inhibitors: Emerging Anticancer Therapeutic Agents?
Kristeleit, R. S., Fong, P. C. C., Aherne, G. W., & Bono, J. S. D. (2005) · Clinical Lung Cancer · doi:10.3816/clc.2005.s.004 · Cited by 25
Patho-epigenetics: histone deacetylases as targets of pathogens and therapeutics
Schator, D., Gómez-Valero, L., Buchrieser, C., & Rolando, M. (2021) · microLife · doi:10.1093/femsml/uqab013 · Cited by 25
Meschini, R., Morucci, E., Berni, A., Lopez-Martinez, W., & Palitti, F. (2015) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2015.04.009 · Cited by 25
Hassanzadeh, M., Bagherzadeh, K., & Amanlou, M. (2016) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2016.10.007 · Cited by 25
Marson, C. M., Savy, P., Rioja, A. S., Mahadevan, T., Mikol, C., Veerupillai, A., Nsubuga, E., Chahwan, A., & Joel, S. P. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm051010j · Cited by 25
Critical review of non‐histone human substrates of metal‐dependent lysine deacetylases
Toro, T. B., & Watt, T. J. (2020) · The FASEB Journal · doi:10.1096/fj.202001301rr · Cited by 24
Yang, W., Li, L., Ji, X., Wu, X., Su, M., Li, S., Zang, Y., Li, J. X., & Liu, H. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.08.030 · Cited by 24
Molecular brake pad hypothesis: pulling off the brakes for emotional memory
Ciernia, A. V., & Wood, M. A. (2012) · Reviews in the Neurosciences · doi:10.1515/revneuro-2012-0050 · Cited by 24
Evolution of Slow-Binding Inhibitors Targeting Histone Deacetylase Isoforms
Mukherjee, A., Zamani, F., & Suzuki, T. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01160 · Cited by 24
Gong, W., Wu, R., & Zhang, Y. (2015) · Journal of Computational Chemistry · doi:10.1002/jcc.24203 · Cited by 24
SAHA-based novel HDAC inhibitor design by core hopping method
Zang, L., Wang, X., Li, X., Wang, S., Xu, W., Xian-bin, X., Cheng, X., Ma, H., & Wang, R. (2014) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2014.08.005 · Cited by 24
Li, H., Ye, H., Chen, C., Yin, L.-H., Wu, J., He, L., & Gao, S. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24967 · Cited by 24
Chromatin modification and disease
Johnson, C. A. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.12.905 · Cited by 24
Roles of Histone Acetyltransferases and Deacetylases in the Retinal Development and Diseases
Wang, J., Feng, S., Zhang, Q., Qin, H., Xu, C., Fu, X., Yan, L., Zhao, Y., & Yao, K. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03213-1 · Cited by 24
Xu, M., Hou, Y., Li, N., Yu, W., & Chen, L. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05169-9 · Cited by 24
Glaser, K. B., Li, J., Aakre, M. E., Morgan, D. W., Sheppard, G. S., Stewart, K. D., Pollock, J. S., Lee, P., O'Connor, C. Z., Anderson, S. N., et al. (2002) · PubMed · Cited by 24
The application of epigenetic modifiers on the treatment of prostate and bladder cancer
Zhang, Z., Karam, J. A., Frenkel, E. P., Sagalowsky, A. I., & Hsieh, J. (2006) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.11.004 · Cited by 24
Marson, C. M., Mahadevan, T., Dines, J., Sengmany, S., Morrell, J. M., Alao, J. P., Joel, S. P., Vigushin, D. M., & Coombes, R. C. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.09.085 · Cited by 24
Inhibition of histone deacetylase activity is a novel function of the antifolate drug methotrexate
Yang, P., Lin, J., Huang, W.-Y., Lin, Y.-C., Yeh, S.-H., & Chen, C. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.072 · Cited by 24
New Molecular Targets and Novel Agents in the Treatment of Advanced Urothelial Cancer
Beekman, K. W., Bradley, D., & Hussain, M. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.12.007 · Cited by 24
Antitumor Activity of Histone Deacetylase Inhibitor Trichostatin A in Osteosarcoma Cells
Cheng, D., Yang, Q., Zhang, Z., Yang, C., & Liu, Y.-W. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.4.1395 · Cited by 24
Metadata
- Authors
- Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Columbia University (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Pavletich, Nikola P.
- Venue
- Nature
- Published
- 1999-09
- Volume
- 401
- Issue
- 6749
- Pages
- 188-193
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2135830745
- Cited by
- 1,714
- References
- 28
- Citations by year
- 2026: 39 · 2025: 48 · 2024: 40 · 2023: 55 · 2022: 28 · 2021: 66 · 2020: 62 · 2019: 50 · 2018: 52 · 2017: 70 · 2016: 68 · 2015: 74 · 2014: 67 · 2013: 78 · 2012: 82
- FWCI
- 12.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Genentech
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- histone deacetylase, histone deacetylase inhibitors, trichostatin A, vorinostat, Aquifex aeolicus, crystal structure, catalytic site, zinc binding site, hyperthermophilic bacteria, anticancer agents, promyelocytic leukemia
- MeSH terms
- Vorinostat, Amino Acid Sequence, Enzyme Inhibitors, Escherichia coli, Histone Deacetylases, Humans, Hydroxamic Acids, Models, Molecular, Molecular Sequence Data, Protein Binding, Protein Conformation, Recombinant Fusion Proteins, Zinc, Gram-Negative Aerobic Rods and Cocci, Sequence Homology, Amino Acid, Crystallography, X-Ray, Catalytic Domain, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.